US Patent Issued to Vaxxinova US on July 28 for "Proteins and immunizing compositions containing Klebsiella proteins and methods of use" (Minnesota Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,167, issued on July 28, was assigned to Vaxxinova US Inc. (Willmar, Minn.).

"Proteins and immunizing compositions containing Klebsiella proteins and methods of use" was invented by Douglas T. Burkhardt (Dassel, Minn.), Daryll Emery (New London, Minn.) and Darren Straub (New London, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are isolated proteins isolatable from a Klebsiella spp. Also provided are compositions that include one or more of the proteins, and methods for making and methods for using the proteins."

The patent was filed on Dec. 6, 2023, under Application No. 18/530,348.

*For further information, including images...